Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000472908 | SCV000555637 | likely benign | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2024-01-24 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001696903 | SCV000726624 | likely benign | not provided | 2020-02-25 | criteria provided, single submitter | clinical testing | |
CHEO Genetics Diagnostic Laboratory, |
RCV000770165 | SCV000901591 | likely benign | Cardiomyopathy | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002356718 | SCV002658326 | likely benign | Cardiovascular phenotype | 2019-03-29 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Revvity Omics, |
RCV001696903 | SCV003818372 | likely benign | not provided | 2023-09-07 | criteria provided, single submitter | clinical testing | |
Clinical Genetics, |
RCV001796066 | SCV002034719 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001696903 | SCV002038385 | likely benign | not provided | no assertion criteria provided | clinical testing |